Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025)

Amarin Corp Plcuk (AMRN) reported Other Accumulated Expenses of $18.3 million for Q4 2025, up 4.52% year-over-year from $17.5 million in Q4 2024, and up 4.52% quarter-over-quarter from $17.5 million in Q4 2024.

Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 16 years of Other Accumulated Expenses data on file, last reported at $18.3 million in Q4 2025.

  • Other Accumulated Expenses for Q4 2025 came in at $18.3 million, up 4.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.3 million (up 4.52% YoY), and the FY2025 annual result was $18.3 million, up 4.52% from the prior year.
  • Other Accumulated Expenses grew to $18.3 million in Q4 2025 per AMRN's latest filing, from $17.5 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $45.6 million in Q4 2021 and troughed at $17.5 million in Q4 2024.
  • A 5-year average of $28.0 million and a median of $23.0 million in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses surged 58.42% in 2021, then sank 35.41% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $45.6 million in 2021, then fell by 21.84% to $35.6 million in 2022, then slumped by 35.41% to $23.0 million in 2023, then decreased by 23.79% to $17.5 million in 2024, then advanced by 4.52% to $18.3 million in 2025.
  • Business Quant data shows AMRN's Other Accumulated Expenses at $18.3 million in Q4 2025, $17.5 million in Q4 2024, and $23.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 18.34 Mn
Dec 31, 2024 17.55 Mn
Dec 31, 2023 23.02 Mn
Dec 31, 2022 35.64 Mn
Dec 31, 2021 45.60 Mn
Dec 31, 2020 28.79 Mn
Dec 31, 2019 16.59 Mn
Dec 31, 2018 7.71 Mn
Dec 31, 2017 5.16 Mn
Dec 31, 2016 5.80 Mn
Dec 31, 2015 4.28 Mn
Dec 31, 2014 2.25 Mn
Dec 31, 2013 3.34 Mn
Dec 31, 2012 3.15 Mn
Dec 31, 2011 1.78 Mn
Dec 31, 2010 572,000.00